| |
|
|
|
Innovate Biopharmaceuticals Inc.  
|
|
2.0669 -0.043 (-0.02%) |
03-21 12:03 |
|
Open: |
2.12 |
Pre close: |
2.11 |
Target:
|
3.88
|
|
High: |
2.13 |
Low: |
2.0301 |
Resistance:
|
3.32
4.32
|
|
Volume: |
255,869 |
Market Cap: |
54M |
Support:
|
1.70
1.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.21
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
2.05  |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
2.57 |
Stochastic Oscillator |
%K(14,3):
|
12.66 |
|
MA(250): |
8.83 |
%D(3): |
23.61 |
|
Average Volume(K) |
3-Month: |
35642
|
52-Week |
High:
|
50.50 |
|
10-Days: |
89825 |
Low: |
1.70 |
|
RSI |
RSI(14):
|
48.83 |
Change(%): |
-90.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
3746.1 |
Shares Out. (M) |
26.07 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-343.6 |
Shares Float (M) |
24.75 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.10 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
145.140 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.69 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.59 |
P/CF |
-3.74 |
|
|
|
|
|
|
